Bupa Global, the international health insurance arm of UK-based Bupa, said it has named Sheldon Kenton to succeed Robert Lang as managing director.
Lang is leaving the role to head up Bupa’s International Markets business, the company said. The appointment is subject to regulatory approval.
Kenton, pictured, joined Bupa Global in December as global commercial director, after 18 years with Cigna, and was responsible for growing Bupa Global’s corporate sales and health benefits business. According to the company, Bupa Global has seen “record new business performance in the corporate segment” since he arrived.
Kenton’s appointment to succeed Lang comes in the wake of the creation of Bupa International Markets earlier this month – alongside another new market unit, Europe & Latin America – replacing Bupa’s previous Spain & Latin America, International Development Markets, and Bupa Global entities.
The International Markets unit is comprised of Bupa Global worldwide premium health insurance; Bupa Hong Kong; Quality HealthCare (Hong Kong); and Bupa Thailand, as well as the Bupa Arabia and Max Bupa (India) associate businesses.
Bupa Global currently looks after some 2 million customers around the world, and employs more than 1,800 people globally. Its parent, which is formally called the British United Provident Association, is one of the world’s largest providers of health insurance and healthcare, with more than eight million customers in the UK and some 190 other countries.
Bupa was founded in 1947 by a number of regional provident associations, and remains a privately held company. Around 70% of its revenue comes from health insurance, with the balance of its revenue coming from health and care provision, including 17 hospitals, 336 clinics, 453 care homes, 60 retirement villages, 565 dental centres and 36 optical outlets.
As reported, in June Bupa Global announced the creation of its first jointly-branded range of “tiered” international private medical insurance products with the US-based Blue Cross Blue Shield Association (BCBSA), for the Jersey, Guernsey and Gibraltar markets.
The launch of the new international PMI range follows a 2014 announcement by Bupa and the BCBSA of plans to join forces in order to better develop a global network of healthcare providers.